vs
Side-by-side financial comparison of AVANOS MEDICAL, INC. (AVNS) and GRID DYNAMICS HOLDINGS, INC. (GDYN). Click either name above to swap in a different company.
AVANOS MEDICAL, INC. is the larger business by last-quarter revenue ($180.9M vs $104.1M, roughly 1.7× GRID DYNAMICS HOLDINGS, INC.). AVANOS MEDICAL, INC. runs the higher net margin — -0.7% vs -1.4%, a 0.7% gap on every dollar of revenue. On growth, GRID DYNAMICS HOLDINGS, INC. posted the faster year-over-year revenue change (3.7% vs 0.7%). Over the past eight quarters, GRID DYNAMICS HOLDINGS, INC.'s revenue compounded faster (12.0% CAGR vs 4.4%).
Avanos Medical, Inc. is a medical technology company making clinical medical devices. The company consists of two franchises – Pain Management and Chronic Care – that address reducing the use of opioids while helping patients recover faster and preventing infection.
Escape Dynamics, Inc. was a Colorado-based technology company that operated 2010–2015 focused on bringing to market single-stage-to-orbit reusable electromagnetically powered spaceplanes.
AVNS vs GDYN — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $180.9M | $104.1M |
| Net Profit | $-1.3M | $-1.5M |
| Gross Margin | 47.5% | 34.8% |
| Operating Margin | 1.4% | 61.7% |
| Net Margin | -0.7% | -1.4% |
| Revenue YoY | 0.7% | 3.7% |
| Net Profit YoY | 99.7% | -150.6% |
| EPS (diluted) | $-0.02 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $104.1M | ||
| Q4 25 | $180.9M | $106.2M | ||
| Q3 25 | $177.8M | $104.2M | ||
| Q2 25 | $175.0M | $101.1M | ||
| Q1 25 | $167.5M | $100.4M | ||
| Q4 24 | $179.6M | $100.3M | ||
| Q3 24 | $170.4M | $87.4M | ||
| Q2 24 | $171.7M | $83.0M |
| Q1 26 | — | $-1.5M | ||
| Q4 25 | $-1.3M | $306.0K | ||
| Q3 25 | $-1.4M | $1.2M | ||
| Q2 25 | $-76.8M | $5.3M | ||
| Q1 25 | $6.6M | $2.9M | ||
| Q4 24 | $-397.3M | $4.5M | ||
| Q3 24 | $4.3M | $4.3M | ||
| Q2 24 | $1.8M | $-817.0K |
| Q1 26 | — | 34.8% | ||
| Q4 25 | 47.5% | 34.0% | ||
| Q3 25 | 48.4% | 33.3% | ||
| Q2 25 | 52.6% | 34.1% | ||
| Q1 25 | 53.6% | 36.8% | ||
| Q4 24 | 54.6% | 36.9% | ||
| Q3 24 | 54.5% | 37.4% | ||
| Q2 24 | 55.7% | 35.6% |
| Q1 26 | — | 61.7% | ||
| Q4 25 | 1.4% | 0.5% | ||
| Q3 25 | 0.1% | -0.2% | ||
| Q2 25 | -42.6% | -0.1% | ||
| Q1 25 | 6.1% | -2.0% | ||
| Q4 24 | -233.0% | 1.3% | ||
| Q3 24 | 7.0% | 2.4% | ||
| Q2 24 | 3.7% | 0.0% |
| Q1 26 | — | -1.4% | ||
| Q4 25 | -0.7% | 0.3% | ||
| Q3 25 | -0.8% | 1.1% | ||
| Q2 25 | -43.9% | 5.2% | ||
| Q1 25 | 3.9% | 2.9% | ||
| Q4 24 | -221.2% | 4.5% | ||
| Q3 24 | 2.5% | 4.9% | ||
| Q2 24 | 1.0% | -1.0% |
| Q1 26 | — | $-0.02 | ||
| Q4 25 | $-0.02 | $0.01 | ||
| Q3 25 | $-0.03 | $0.01 | ||
| Q2 25 | $-1.66 | $0.06 | ||
| Q1 25 | $0.14 | $0.03 | ||
| Q4 24 | $-8.64 | $0.06 | ||
| Q3 24 | $0.09 | $0.05 | ||
| Q2 24 | $0.04 | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.8M | $327.5M |
| Total DebtLower is stronger | $90.3M | — |
| Stockholders' EquityBook value | $778.2M | $530.1M |
| Total Assets | $1.1B | $605.0M |
| Debt / EquityLower = less leverage | 0.12× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $327.5M | ||
| Q4 25 | $89.8M | $342.1M | ||
| Q3 25 | $70.5M | $338.6M | ||
| Q2 25 | $90.3M | $336.8M | ||
| Q1 25 | $97.0M | $325.5M | ||
| Q4 24 | $107.7M | $334.7M | ||
| Q3 24 | $89.0M | $231.3M | ||
| Q2 24 | $92.2M | $256.0M |
| Q1 26 | — | — | ||
| Q4 25 | $90.3M | — | ||
| Q3 25 | $93.4M | — | ||
| Q2 25 | $95.7M | — | ||
| Q1 25 | $98.0M | — | ||
| Q4 24 | $125.3M | — | ||
| Q3 24 | $152.6M | — | ||
| Q2 24 | $164.9M | — |
| Q1 26 | — | $530.1M | ||
| Q4 25 | $778.2M | $542.1M | ||
| Q3 25 | $778.0M | $537.7M | ||
| Q2 25 | $776.3M | $532.2M | ||
| Q1 25 | $839.4M | $517.4M | ||
| Q4 24 | $828.5M | $517.8M | ||
| Q3 24 | $1.2B | $400.2M | ||
| Q2 24 | $1.2B | $388.4M |
| Q1 26 | — | $605.0M | ||
| Q4 25 | $1.1B | $612.9M | ||
| Q3 25 | $1.1B | $613.2M | ||
| Q2 25 | $1.0B | $608.9M | ||
| Q1 25 | $1.1B | $590.9M | ||
| Q4 24 | $1.2B | $592.2M | ||
| Q3 24 | $1.7B | $477.3M | ||
| Q2 24 | $1.7B | $443.6M |
| Q1 26 | — | — | ||
| Q4 25 | 0.12× | — | ||
| Q3 25 | 0.12× | — | ||
| Q2 25 | 0.12× | — | ||
| Q1 25 | 0.12× | — | ||
| Q4 24 | 0.15× | — | ||
| Q3 24 | 0.12× | — | ||
| Q2 24 | 0.13× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $28.2M | — |
| Free Cash FlowOCF − Capex | $21.3M | — |
| FCF MarginFCF / Revenue | 11.8% | — |
| Capex IntensityCapex / Revenue | 3.8% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $43.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $28.2M | $9.9M | ||
| Q3 25 | $14.0M | $7.0M | ||
| Q2 25 | $6.8M | $14.4M | ||
| Q1 25 | $25.7M | $9.4M | ||
| Q4 24 | $57.9M | $7.1M | ||
| Q3 24 | $23.0M | $9.2M | ||
| Q2 24 | $27.8M | $10.7M |
| Q1 26 | — | — | ||
| Q4 25 | $21.3M | $6.1M | ||
| Q3 25 | $7.0M | $2.9M | ||
| Q2 25 | $-4.2M | $10.2M | ||
| Q1 25 | $19.0M | $6.0M | ||
| Q4 24 | $53.1M | $4.4M | ||
| Q3 24 | $20.0M | $5.9M | ||
| Q2 24 | $21.9M | $8.0M |
| Q1 26 | — | — | ||
| Q4 25 | 11.8% | 5.7% | ||
| Q3 25 | 3.9% | 2.8% | ||
| Q2 25 | -2.4% | 10.1% | ||
| Q1 25 | 11.3% | 6.0% | ||
| Q4 24 | 29.6% | 4.4% | ||
| Q3 24 | 11.7% | 6.8% | ||
| Q2 24 | 12.8% | 9.7% |
| Q1 26 | — | — | ||
| Q4 25 | 3.8% | 3.6% | ||
| Q3 25 | 3.9% | 3.9% | ||
| Q2 25 | 6.3% | 4.1% | ||
| Q1 25 | 4.0% | 3.3% | ||
| Q4 24 | 2.7% | 2.6% | ||
| Q3 24 | 1.8% | 3.7% | ||
| Q2 24 | 3.4% | 3.2% |
| Q1 26 | — | — | ||
| Q4 25 | — | 32.34× | ||
| Q3 25 | — | 5.92× | ||
| Q2 25 | — | 2.73× | ||
| Q1 25 | 3.89× | 3.21× | ||
| Q4 24 | — | 1.56× | ||
| Q3 24 | 5.35× | 2.15× | ||
| Q2 24 | 15.44× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AVNS
| Enteral Feeding | $83.0M | 46% |
| Radiofrequency Ablation | $36.9M | 20% |
| Neonate Solutions | $32.1M | 18% |
| Surgical Pain And Recovery | $24.7M | 14% |
| Corporate Other | $4.2M | 2% |
GDYN
Segment breakdown not available.
